Jain Global’s MediciNova MNOV Stock Holding History

Jain Global’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,264	Closed	-$15K	–	1464
2025 Q1	$15K	Buy	+10,264	New	+$18.2K	﹤0.01%	1041

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jain Global's MNOV Position: Q2 2025 in Review

Jain Global sold out of MediciNova (MNOV) in Q2 2025, closing a stake of 10,264 shares — an estimated $15K sold.

Jain Global first reported a position in MNOV in Q1 2025 and held it in 1 quarter. The position peaked at $15K in Q1 2025. 23 funds tracked by Wall St. Rank hold MNOV as of Q2 2025.

Jain Global reported no remaining MediciNova position as of Q2 2025 after selling out during the quarter.
Jain Global sold 10,264 MediciNova shares in Q2 2025, an estimated $15K.
Jain Global first reported a position in MediciNova in Q1 2025 and held it in 1 quarter.
Jain Global's MediciNova position peaked at $15K in Q1 2025.
23 funds tracked by Wall St. Rank held MediciNova as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.